BVS (Bioventus Corp) EV/EBITDA Multiple
The dynamic EV/EBITDA value of Bioventus Inc. (BVS) demonstrates market equilibrium, with the value holding at 11.54. Growth is driven by the expansion of minimally invasive osteoarthritis treatments in US clinics. A positive vector is supported by developments in ultrasonic fracture healing and the optimization of raw material inventories, which completely eliminates supply chain disruptions for orthopedic devices.
Summary analytical data breakdowns for bioventus.com (BVS)
- stock price and consensus target price:
- business market valuation indicators:
- issuer book value statistics:
- debt and liquidity data:
- financial results and valuation multiples details:
BVS - Net Income|Projected Future Earnings Bioventus Inc.|BVS - P/E Multiple|Future Price to Earnings Bioventus Inc.|BVS - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Bioventus Global|BVS - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Bioventus|BVS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months bioventus.com|BVS - Net earnings per share change in current year|Expected earnings per share growth for next year Bioventus Inc.
Initial company analysis:Bioventus Corp BVS
To objectively assess the investment attractiveness of Bioventus Inc. (BVS), it is critical to analyze the ratio of total enterprise value to operating profit before depreciation and interest. The company's EV/EBITDA multiple, accounting for debt load, reflects the asset's market value relative to its ability to generate cash flow, which is particularly significant when utilizing an asset-light model with contract manufacturing.
Competitor analysis for Bioventus Inc.
Boston Scientific Inc - Enterprise Value to EBITDA Ratio|EW (Edwards Lifesciences Inc.) - Company Value to Operating Income Before Depreciation Ratio|ResMed Inc. - EV/EBITDA Multiple|Company Value to EBITDA insulet.com|ZBH: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation COO|Enterprise Value to EBITDA Ratio ALGN|GMED: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TransMedics (TMDX)|Enterprise Value to EBITDA Ratio atecspine.com ATEC|EV/EBITDA Multiple AORT (Artivion)|Enovis Corp (ENOV) - Company Value to EBITDA|Integra - EV/EBITDA Multiple|ESTA (Establishment Labs Inc) - Enterprise Value to Operating Income Before Depreciation|BBNX: EV/EBITDA Multiple|IRMD - Total Company Value to Operating Income Before Depreciation Ratio|EMBC (Embecta) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Tandem Diabetes Care Inc (TNDM)|EV/EBITDA Multiple AXGN|EV/EBITDA Multiple SI-BONE Medical (SIBN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orthofix Medical Inc. OFIX|OrthoPediatrics Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation SRTA (Blade Air Mobility)|CARL: EV/EBITDA Multiple|Company Value to EBITDA RxSight Ophthalmic (RXST)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ClearPoint Neuro Inc.|STXS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio STIM (Neuronetics)|EV/EBITDA Multiple Sight Sciences Inc. (SGHT)|EV/EBITDA Multiple OBIO (Orchestra BioMed)|Total Company Value to Operating Income Before Depreciation Ratio Anika Therapeutics Inc. (ANIK)|NSPR - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Xtant Medical|NMTC (NeuroOne Corp) - EV/EBITDA Multiple|Company Value to EBITDA Modular Med MODD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Myomo, Inc. (MYO)|envoymedical.com - Enterprise Value to Operating Income Before Depreciation|Vivos Therapeutics, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NVNO (enVVeno Medical Corporation)|SINTX Technologies - EV/EBITDA Multiple|TNON: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LFWD: EV/EBITDA Multiple|AMIX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|Company Value to EBITDA Bone Biologics Corp. BBLG|Enterprise Value to EBITDA Ratio AXNX (Axonics Modulation Technologies)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BIOL (Biolase Inc.)|EV/EBITDA Multiple DYNT (Dynatronics)|Paragon 28 Inc. (FNA) - Company Value to EBITDA|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
